Prostatype Genomics AB (publ)

OM:PROGEN Stock Report

Market Cap: SEK 7.7m

Prostatype Genomics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OM:PROGEN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Sep 24SellSEK 41,098Anders LundbergIndividual1,749.85SEK 23.98

Insider Trading Volume

Insider Buying: PROGEN insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of PROGEN?
Owner TypeNumber of SharesOwnership Percentage
Institutions3,0990.313%
Individual Insiders82,9688.37%
Private Companies108,86411%
General Public795,88080.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 729.4%.


Top Shareholders

Top 10 shareholders own 19.67% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11%
Aj Lundberg KapitalfÖRvaltning Ab
108,864SEK 849.1k2,860%no data
7.49%
Michael Haggman
74,191SEK 578.7k11,600%no data
0.85%
Hakan Englund
8,462SEK 66.0k0%no data
0.31%
Creathor Venture Management GmbH
3,080SEK 24.0k0%no data
0.018%
Fredrik Rickman
175SEK 1.4k0%no data
0.01%
Jörgen Dahlström
100SEK 779.80%no data
0.0019%
FCG Fonder AB
19SEK 148.40%no data
0.0019%
Michael Winklerfelt
19SEK 148.40%no data
0.0011%
Emelie Berglund
11SEK 85.80%no data
0.001%
Karlheinz Schmelig
10SEK 78.10%no data